APPLICATION
ANDA083666
TYPE
ANDA
LATEST ACTION
1988-11-30
ROUTE
ORAL
DOSAGE FORM
TABLET
MARKETING STATUS
Discontinued
Products
HYDROCHLOROTHIAZIDE W/ RESERPINEDiscontinued
HYDROCHLOROTHIAZIDE 50MG, RESERPINE 0.125MG · TABLET · ORAL
Approval history
1988-11-30Manufacturing (CMC) · Supplement 31AP
1988-08-26Manufacturing (CMC) · Supplement 30AP
1988-03-08Manufacturing (CMC) · Supplement 29AP
1987-12-04Manufacturing (CMC) · Supplement 28AP
1986-02-25Manufacturing (CMC) · Supplement 27AP
1983-12-06Manufacturing (CMC) · Supplement 24AP
1982-03-29Manufacturing (CMC) · Supplement 18AP
Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.
Weekly Briefing
Read a past issue →Get the Weekly GxP Briefing
Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.